Literature DB >> 683625

Hansen's disease in pregnancy.

J N Maurus.   

Abstract

Hansen's disease with pregnancy is an uncommon concurrence in the United States. The clinical courses of 62 pregnancies in 26 treated patients with various types of Hansen's disease are reported. In general, patients with Hansen's disease do well in pregnancy. However, the subgroups of active lepromatous and dimorphous types have an increased incidence of obstetric and disease complications. Additional important observations include a high incidence of false-positive biologic tests for syphilis, with the possibility that the FTA-ABS test may also be falsely positive in pregnant patients with Hansen's disease. Sulfone drugs may be used safely during pregnancy. There is a low incidence of congenital malformations, but an unusually high incidence of twinning in this small group of patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683625

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Authors:  M Keuter; A van Eijk; M Hoogstrate; M Raasveld; M van de Ree; W A Ngwawe; W M Watkins; J B Were; A D Brandling-Bennett
Journal:  BMJ       Date:  1990-09-08

Review 2.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

Review 3.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 4.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  Obstetric infections.

Authors:  H A Oster
Journal:  West J Med       Date:  1981-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.